Trial Profile
A retrospective study to evaluate predictors of response in patients with hepatocellular carcinoma who received adjuvant sorafenib after curative resection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 29 Mar 2016 New trial record